VERV

Verve Therapeutics, Inc. VERV

Trading inactive

Analyst Consensus

Price Objectif

Analyst historical

Analyst Entreprise Price during analysis Target price Potential gain Publication date
Mitchell Kapoor H.C. Wainwright 6.315 $ 14 $ 7.69 % 06/11/2024
Kostas Biliouris BMO Capital 8.57 $ 30 $ 21.43 % 03/04/2024